BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 30655073)

  • 1. Is irreversible electroporation safe and effective in the treatment of hepatobiliary and pancreatic cancers?
    Wu LM; Zhang LL; Chen XH; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):117-124. PubMed ID: 30655073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
    Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
    Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy.
    Ansari D; Kristoffersson S; Andersson R; Bergenfeldt M
    Scand J Gastroenterol; 2017 Nov; 52(11):1165-1171. PubMed ID: 28687047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
    Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
    Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
    Flak RV; Stender MT; Jensen TM; Andersen KL; Henriksen SD; Mortensen PB; Sall M; Thorlacius-Ussing O
    Scand J Gastroenterol; 2019 Feb; 54(2):252-258. PubMed ID: 30907286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible electroporation for the ablation of liver tumors: are we there yet?
    Charpentier KP
    Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
    Martin RC; McFarland K; Ellis S; Velanovich V
    J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
    Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
    Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
    Kwon D; McFarland K; Velanovich V; Martin RC
    Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from the AHPBA pancreatic registry.
    Holland MM; Bhutiani N; Kruse EJ; Weiss MJ; Christein JD; White RR; Huang KW; Martin RCG
    HPB (Oxford); 2019 Aug; 21(8):1024-1031. PubMed ID: 30737097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy.
    Simmerman E; Chung J; Lawson A; Kruse E
    J Surg Res; 2020 Feb; 246():260-268. PubMed ID: 31610354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer.
    Moir J; White SA; French JJ; Littler P; Manas DM
    Eur J Surg Oncol; 2014 Dec; 40(12):1598-604. PubMed ID: 25307210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience.
    Lambert L; Horejs J; Krska Z; Hoskovec D; Petruzelka L; Krechler T; Kriz P; Briza J
    Neoplasma; 2016; 63(2):269-73. PubMed ID: 26774149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC).
    Oikonomou D; Karamouzis MV; Moris D; Dimitrokallis N; Papamichael D; Kountourakis P; Astras G; Davakis S; Papalampros A; Schizas D; Petrou AS; Felekouras E
    Am J Clin Oncol; 2021 Jul; 44(7):325-330. PubMed ID: 33979098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of resistance as a measure of successful tumor ablation during irreversible electroporation of the pancreas.
    Dunki-Jacobs EM; Philips P; Martin RC
    J Am Coll Surg; 2014 Feb; 218(2):179-87. PubMed ID: 24315888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients.
    Kluger MD; Epelboym I; Schrope BA; Mahendraraj K; Hecht EM; Susman J; Weintraub JL; Chabot JA
    Ann Surg Oncol; 2016 May; 23(5):1736-43. PubMed ID: 26714959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma.
    Narayanan G; Hosein PJ; Arora G; Barbery KJ; Froud T; Livingstone AS; Franceschi D; Rocha Lima CM; Yrizarry J
    J Vasc Interv Radiol; 2012 Dec; 23(12):1613-21. PubMed ID: 23177107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.
    Martin RC; McFarland K; Ellis S; Velanovich V
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S443-9. PubMed ID: 23128941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
    He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
    Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.